Fundz

Who to call at APPLIED THERAPEUTICS, INC., and when

Fundz watches for the moments APPLIED THERAPEUTICS, INC. starts buying, and tells you who to reach.

  • An alert the day APPLIED THERAPEUTICS, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at APPLIED THERAPEUTICS, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at APPLIED THERAPEUTICS, INC.. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KHIGH RiskNegative

APPLIED THERAPEUTICS, INC.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

appliedtherapeutics.com
Filed: Nov 9, 2025NEW YORK, New YorkCIK: 0001697532Healthcare
Full company profileView on SEC.gov

2 executive changes at Applied Therapeutics in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

See every company with multiple executive changes →

AI Executive Summary

AI-powered analysis of 8-K filing content

John H. Johnson resigned effective immediately as Executive Chairman and director of Applied Therapeutics on November 9, 2025, with no disagreement cited and no successor named. The company also reported Q3 2025 results on November 13, 2025, and is currently led on an interim basis by Les Funtleyder, who serves as both Interim CEO and CFO.

Key Takeaways

John H. Johnson resigned as Executive Chairman and as a director, effective immediately, on November 9, 2025.

The filing states the resignation was not due to any disagreement with the company, management, or the Board on operations, policies, or practices.

3 more takeaways

Related Filings (4)

4 more filings from APPLIED THERAPEUTICS, INC. in the last 90 days

Filing Overview

Form Type8-K
Filing DateNov 9, 2025
Item5.02
CategoryExecutive Change
CIK0001697532
Accession #0001697532
Risk LevelHIGH
SentimentNegative
Signalrisk
Topics
executive departureboard changeearnings

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

APPLIED THERAPEUTICS, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.